[go: up one dir, main page]

AR023389A1 - NEW USE - Google Patents

NEW USE

Info

Publication number
AR023389A1
AR023389A1 ARP000101558A ARP000101558A AR023389A1 AR 023389 A1 AR023389 A1 AR 023389A1 AR P000101558 A ARP000101558 A AR P000101558A AR P000101558 A ARP000101558 A AR P000101558A AR 023389 A1 AR023389 A1 AR 023389A1
Authority
AR
Argentina
Prior art keywords
new use
headache
treatment
low affinity
nmda antagonists
Prior art date
Application number
ARP000101558A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR023389A1 publication Critical patent/AR023389A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

El uso de antagonistas de NMDA de baja afinidad, para el tratamiento del dolor de cabeza.The use of low affinity NMDA antagonists, for the treatment of headache.

ARP000101558A 1999-04-06 2000-04-05 NEW USE AR023389A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (en) 1999-04-06 1999-04-06 Novel use

Publications (1)

Publication Number Publication Date
AR023389A1 true AR023389A1 (en) 2002-09-04

Family

ID=20415133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101558A AR023389A1 (en) 1999-04-06 2000-04-05 NEW USE

Country Status (4)

Country Link
AR (1) AR023389A1 (en)
AU (1) AU3994100A (en)
SE (1) SE9901237D0 (en)
WO (1) WO2000059496A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648745A1 (en) * 1988-08-12 1995-04-19 Astra Aktiebolag Arylalkylamine having anticonvulsant and neuroprotective properties
AU643365B2 (en) * 1991-02-28 1993-11-11 Aventisub Ii Inc. NMDA antagonists
CA2133427C (en) * 1992-04-03 2003-06-10 Ronald Conrad Griffith Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
IS4233A (en) * 1993-12-22 1995-06-23 Astra Aktiebolag Misguided ring-related compounds
DE19510189A1 (en) * 1995-03-21 1996-09-26 Hartmut Dr Goebel Use of amantadine
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache

Also Published As

Publication number Publication date
SE9901237D0 (en) 1999-04-06
AU3994100A (en) 2000-10-23
WO2000059496A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
BR0114829A (en) New compounds
TR200202194T2 (en) Polyglutamic acid-camptothecin compounds and preparation methods
MXPA03007140A (en) Chemical compounds.
DE69728585D1 (en) Antipruritic agent
ECSP045081A (en) DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
BR9706934A (en) New substituted imidazole compounds
UY27079A1 (en) PROCEDURE FOR THE PREPARATION OF AN ANTICHOLINERGIC
BR9810342A (en) New imidazole compounds replaced
UY28342A1 (en) NEW COMPOUNDS
AR020442A1 (en) 5HT2SEROTONERGIC AGONISTS FOR THE TREATMENT OF GLAUCOMA
ES2190246T3 (en) NEW THIAZOLOPIRIMIDINE COMPOUNDS.
BR0215405A (en) Compositions and processes of use of collajolie
UY27098A1 (en) INDOL DERIVATIVES
UY28348A1 (en) NEW COMPOUNDS
DE60216233D1 (en) Carbolinderivate
BR0114903A (en) 7-azaindoles, their application as phosphodiesterase 4 inhibitors and processes for their preparation
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
BR0309053A (en) Compounds
BR0114379A (en) Substituted c-cyclohexylmethylamine derivatives
ATE302776T1 (en) CONDENSED PYRIDOINDOLE DERIVATIVES
EA200300727A1 (en) DERIVATIVES OF 2H-1-BENZOPIRANE, METHODS OF THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS
UY27031A1 (en) USE OF DOPAMINE D4 RECEPTOR SELECTIVE AGONISTS TO TREAT SEXUAL DYSFUNCTION
BR0206917A (en) Use of mglur5 antagonists to treat pruritic conditions